Journal
JOURNAL OF CYSTIC FIBROSIS
Volume 9, Issue 4, Pages 257-262Publisher
ELSEVIER
DOI: 10.1016/j.jcf.2010.03.011
Keywords
-
Categories
Funding
- Lundbeck Foundation
- Roche A/S Denmark
- Lundbeck Foundation [R5-2006-446] Funding Source: researchfish
Ask authors/readers for more resources
Background: Cystic fibrosis (CF) affects the lungs causing infections and inflammation. Surfactant protein D (SP-D) is an innate defense lectin primarily secreted in the lungs. We investigated the influence of the SP-D Met11Thr polymorphism on CF lung function; and serum SP-D as a marker for CF lung disease. Methods: For 107 CF patients (73 children, and 34 adults) serum SP-D and SP-D Met11Thr genotype were available. Leukocyte count was obtained for a subset of patients. Lung function was measured as forced expiratory volume in one second (FEV-1). Results: Serum SP-D was increased in CF patients compared to healthy controls, positively correlated to leukocyte count, and negatively conelated to FEV-1. We found no correlation between SP-D Met11Thr genotype and FEV-1, and we found corresponding genotype frequencies in CF patients and in healthy controls. Conclusion: Serum SP-D in CF patients was increased in parallel with leukocyte count and with reduced FEV-1 and may constitute an alternative biomarker for lung disease, in the clinical setting and in research. (C) 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available